A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ethynodiol diacetate
Reviparin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Reviparin.
Ethynodiol diacetate
Bemiparin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Bemiparin.
Ethynodiol diacetate
Arotinolol
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Arotinolol.
Ethynodiol diacetate
Aliskiren
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Aliskiren.
Ethynodiol diacetate
Temocapril
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Temocapril.
Ethynodiol diacetate
Azilsartan medoxomil
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Azilsartan medoxomil.
Ethynodiol diacetate
Nadroparin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Nadroparin.
Ethynodiol diacetate
Bopindolol
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Bopindolol.
Ethynodiol diacetate
Tinzaparin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Tinzaparin.
Ethynodiol diacetate
Dalteparin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Dalteparin.
Ethynodiol diacetate
Ammonium chloride
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Ammonium chloride.
Ethynodiol diacetate
Saralasin
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Saralasin.
Ethynodiol diacetate
Danaparoid
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Danaparoid.
Ethynodiol diacetate
Bufuralol
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Bufuralol.
Ethynodiol diacetate
Sulodexide
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Sulodexide.
Ethynodiol diacetate
Penicillin G Acyl-Serine
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Penicillin G Acyl-Serine.
Ethynodiol diacetate
Penbutolol
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Penbutolol.
Ethynodiol diacetate
Tasosartan
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Tasosartan.
Ethynodiol diacetate
Spirapril
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Spirapril.
Ethynodiol diacetate
Saprisartan
The risk or severity of hyperkalemia can be increased when Nadolol is combined with Saprisartan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3